Intervention of Pharmaceutical Care on Rational Drug Use in Children with Nephrotic Syndrome

Duan Yanyan; Ma Shuli; Pei Baofang; Chen Haiyan

doi:10.13407/j.cnki.jpp.1672-108X.2021.04.012

您当前的位置：

首页 >

文章列表页 >

Intervention of Pharmaceutical Care on Rational Drug Use in Children with Nephrotic Syndrome

更新时间：2022-11-03

- Intervention of Pharmaceutical Care on Rational Drug Use in Children with Nephrotic Syndrome
- Vol. 27, Issue 4, Pages: 40-42(2021)
- 作者机构：
  
  郑州大学附属儿童医院，河南省儿童医院，郑州儿童医院,河南,郑州,450000
- 作者简介：
- 基金信息：
- DOI：10.13407/j.cnki.jpp.1672-108X.2021.04.012
  CLC：
- Published：2021，
  
  Published Online：10 April 2021，
扫描看全文
Duan Yanyan, Ma Shuli, Pei Baofang, et al. Intervention of Pharmaceutical Care on Rational Drug Use in Children with Nephrotic Syndrome. [J]. 27(4):40-42(2021)
DOI：

Duan Yanyan, Ma Shuli, Pei Baofang, et al. Intervention of Pharmaceutical Care on Rational Drug Use in Children with Nephrotic Syndrome. [J]. 27(4):40-42(2021) DOI： 10.13407/j.cnki.jpp.1672-108X.2021.04.012.

摘要

目的：评价临床药师开展药学服务对肾病综合征患儿合理用药的影响。方法：抽取我院肾病综合征住院患儿病历非干预组81份（2018年1-6月）及干预组83份（2018年7-12月），对比两组患儿用药依从性、不良反应发生率、治疗效果及对疾病认知方面差异。结果：干预组和非干预组用药依从性评分为（6.74±1.13）分和（3.25±1.56）分（P<0.05）；干预组在视物模糊、骨质疏松、糖尿病的不良反应发生率分别为3.61%、2.41%、0，均低于非干预组12.35%、9.87%、4.94%（P<0.05）；疾病认知方面干预组明显优于非干预组（P<0.05）。结论：通过临床药师系统全面的药学服务，能降低肾病综合征患儿药品不良反应的发生，提高用药的依从性及对疾病的认知程度。

Abstract

Objective: To evaluate the effects of pharmaceutical care by clinical pharmacists on the rational drug use in children with nephrotic syndrome. Methods: Medical records of hospitalized children with nephrotic syndrome in our hospital were collected from 81 cases in the non-intervention group (from Jan. to Jun. 2018) and 83 cases in the intervention group (from Jul. to Dec. 2018). Differences in medication compliance

incidence of adverse drug reactions

treatment effects and disease cognition between two groups were compared. Results: The medication compliance scores of the intervention group and non-intervention group were respectively (6.74±1.13) points and (3.25±1.56) points (P<0.05). The incidences of adverse drug reactions in the intervention group such as blurred vision

osteoporosis and diabetes were respectively 3.61%

2.41%

and 0

lower than 12.35%

9.87%

and 4.94% in the non-intervention group (P<0.05). In terms of disease cognition

the intervention group was significantly better than the non-intervention group (P<0.05). Conclusion: Comprehensive pharmaceutical care by clinical pharmacists can reduce the incidence of adverse drug reactions in children with nephrotic syndrome

improve the medication compliance and the degree of cognition of the disease.

关键词

临床药师肾病综合征用药依从性药学服务

Keywords

clinical pharmacistsnephrotic syndromemedication compliancepharmaceutical care

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Participation in the Treatment of a Child with Ectopic Adrenocorticotropic Hormone Syndrome Induced by Thymic Neuroendocrine Tumor by Clinical Pharmacists

Pharmacological Care for Lower Respiratory Tract Infection in Children with Complicated Congenital Heart Disease after Surgery

Pharmaceutical Care for Children with Steroid-Resistant Nephrotic Syndrome by Pediatric Clinical Pharmacists

Improvement of Pharmaceutical Care with Drug Consultation as the Entry Point

Pharmaceutical Care for a Child with Nephrotic Syndrome Complicated with Drug-Induced Liver Injury

Related Author

Yu Jingjie

Zhang Kanghuai

Huang Xiaojing

Zhao Hongwei

Ma Yongcheng

Wang Aifeng

Hua Ying

Wu Kaiyuan

Related Institution

The Second Affiliated Hospital of Xi’an Jiaotong University

Fuwai Central China Cardiovascular Hospital

Department of Pharmacy, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Department and Disorders, Chongqing Key Laboratory of Pediatrics

The Third Affiliated Hospital of Zhengzhou University, Zhengzhou

The First Affiliated Hospital of Chongqing Medical University

⁰